pyrazolanthrone has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, MY; Chueh, PJ; Huang, CY; Kuo, WW; Tseng, CT; Yang, JJ | 1 |
| Li, BW; Li, Z; Tang, J; Tao, JQ; Wang, JW; Wang, LJ; Wang, WZ; Wei, S; Xie, KL; Xu, H; Xu, ZK; Yang, L; Zhang, DC; Zhang, Q; Zhi, XF; Zhu, Y | 1 |
2 other study(ies) available for pyrazolanthrone and atrial natriuretic factor
| Article | Year |
|---|---|
Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.
Topics: Actins; Angiotensin II; Animals; Anthracenes; Atrial Natriuretic Factor; Cell Size; Cells, Cultured; Humans; Hypertrophy; Interleukins; MAP Kinase Kinase 7; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Phenylephrine; Protein Kinase Inhibitors; Protein Kinases; Rats; Recombinant Fusion Proteins; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2004 |
Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death.
Topics: Acetylcysteine; Adenine; Animals; Anthracenes; Atrial Natriuretic Factor; Autophagy; Cell Line, Tumor; Cell Proliferation; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Neoplasm Staging; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Receptors, Atrial Natriuretic Factor; RNA, Small Interfering; Stomach Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |